Copy to clipboard 
Corin has named David Floyd, Chairman of the Board of Directors, as its interim Chief Executive Officer.
The industry veteran began his orthopedic career at Zimmer in the late ’80s. His experience includes roles at Sulzer Orthopedics, OrthoLogic, Centerpulse, AxioMed Spine, Abbott Spine, DePuy Orthopaedics and Stryker. He also served a term as Chief Executive Officer of industry-focused non-profit OrthoWorx in Warsaw, Indiana and as a board member of contract manufacturer NN, Inc.
As Group President of Orthopaedics at Stryker, Floyd oversaw a number of acquisitions–most notably Mako Surgical, and also Instratek, Small Bone Innovations and Stanmore Implants.
Corin’s previous CEO, Stefano Alfonsi, led the company since 2013, during which time Corin acquired Optimized Ortho, provider of surgical planning and simulation solutions; Global Orthopaedic Technology, manufacturer of hip and knee replacement devices in Australia; Wright Medical’s legacy Tornier hip and knee assets and OMNI, makers of the OMNIBotics robot-assisted total knee. Corin itself was acquired by investment firm Permira in 2018.
Corin’s offerings span ankle replacement, ligament repair/reconstruction and knee and hip reconstruction that is accompanied by digital and robotic technologies.
David Floyd said, “Over the last eight years, Corin has substantially broadened its product portfolio, especially with digital technologies, and its geographic reach. The company continues to lead the way in orthopaedic innovation, providing a faster, positive and more assured return to quality of life for people all over the world. I look forward to working with the Corin team over the coming months to build on the company’s successes and further its goal of revolutionizing orthopaedics.”
Alexandre Margoline, Partner at Permira, said, “Since our funds’ investment in Corin in 2018, the company has made great progress in improving surgical and patient outcomes, transforming the orthopaedics industry, especially through further adoption of innovative software and robotics. We look forward to working with David during the next few months, leveraging his wealth of experience in the industry, as we continue to drive growth at Corin.”
Corin has named David Floyd, Chairman of the Board of Directors, as its interim Chief Executive Officer.
The industry veteran began his orthopedic career at Zimmer in the late '80s. His experience includes roles at Sulzer Orthopedics, OrthoLogic, Centerpulse, AxioMed Spine, Abbott Spine, DePuy Orthopaedics and Stryker. He also served a...
Corin has named David Floyd, Chairman of the Board of Directors, as its interim Chief Executive Officer.
The industry veteran began his orthopedic career at Zimmer in the late ’80s. His experience includes roles at Sulzer Orthopedics, OrthoLogic, Centerpulse, AxioMed Spine, Abbott Spine, DePuy Orthopaedics and Stryker. He also served a term as Chief Executive Officer of industry-focused non-profit OrthoWorx in Warsaw, Indiana and as a board member of contract manufacturer NN, Inc.
As Group President of Orthopaedics at Stryker, Floyd oversaw a number of acquisitions–most notably Mako Surgical, and also Instratek, Small Bone Innovations and Stanmore Implants.
Corin’s previous CEO, Stefano Alfonsi, led the company since 2013, during which time Corin acquired Optimized Ortho, provider of surgical planning and simulation solutions; Global Orthopaedic Technology, manufacturer of hip and knee replacement devices in Australia; Wright Medical’s legacy Tornier hip and knee assets and OMNI, makers of the OMNIBotics robot-assisted total knee. Corin itself was acquired by investment firm Permira in 2018.
Corin’s offerings span ankle replacement, ligament repair/reconstruction and knee and hip reconstruction that is accompanied by digital and robotic technologies.
David Floyd said, “Over the last eight years, Corin has substantially broadened its product portfolio, especially with digital technologies, and its geographic reach. The company continues to lead the way in orthopaedic innovation, providing a faster, positive and more assured return to quality of life for people all over the world. I look forward to working with the Corin team over the coming months to build on the company’s successes and further its goal of revolutionizing orthopaedics.”
Alexandre Margoline, Partner at Permira, said, “Since our funds’ investment in Corin in 2018, the company has made great progress in improving surgical and patient outcomes, transforming the orthopaedics industry, especially through further adoption of innovative software and robotics. We look forward to working with David during the next few months, leveraging his wealth of experience in the industry, as we continue to drive growth at Corin.”
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
